90 related articles for article (PubMed ID: 8453893)
1. Enalapril-associated erythema and vasculitis.
Carrington PR; Sanusi ID; Zahradka S; Winder PR
Cutis; 1993 Feb; 51(2):121-3. PubMed ID: 8453893
[TBL] [Abstract][Full Text] [Related]
2. Enalapril induced normocomplementemic urticarial vasculitis.
Koregol S; Naidu V; Rao S; Ankad BS
Indian J Dermatol Venereol Leprol; 2015; 81(1):73-4. PubMed ID: 25566910
[No Abstract] [Full Text] [Related]
3. Exanthematous drug eruption due to valsartan.
Ozturk G; Turk BG; Senturk B; Turkmen M; Kandiloglu G
Cutan Ocul Toxicol; 2012 Dec; 31(4):335-7. PubMed ID: 22257082
[TBL] [Abstract][Full Text] [Related]
4. ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and Lupus erythematosus tumidus.
Schepis C; Lentini M; Siragusa M; Batolo D
Dermatology; 2004; 208(4):354-5. PubMed ID: 15178923
[No Abstract] [Full Text] [Related]
5. [Enalapril-induced vasculitis].
Ayani I; Martínez MJ; Lekuona I; Manrique P
Med Clin (Barc); 1991 Apr; 96(15):596. PubMed ID: 1828848
[No Abstract] [Full Text] [Related]
6. Interstitial granulomatous drug reaction presenting as erythroderma: remission after discontinuation of enalapril maleate.
Chen YC; Hsiao CH; Tsai TF
Br J Dermatol; 2008 May; 158(5):1143-5. PubMed ID: 18284384
[No Abstract] [Full Text] [Related]
7. Usefulness of patch tests for diagnosing selective allergy to captopril.
Gaig P; San Miguel-Moncin MM; Bartra J; Bonet A; García-Ortega P
J Investig Allergol Clin Immunol; 2001; 11(3):204-6. PubMed ID: 11831455
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous acral nodular eruption and flagellate erythema caused by bleomycin.
Mikhail M; Eichenbaum M; Gerstenfeld E; Duquette J; Pomeranz MK; Polsky D
J Drugs Dermatol; 2005; 4(1):81-4. PubMed ID: 15696989
[TBL] [Abstract][Full Text] [Related]
9. Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides.
Furness PN; Goodfield MJ; MacLennan KA; Stevens A; Millard LG
J Clin Pathol; 1986 Aug; 39(8):902-7. PubMed ID: 3018050
[TBL] [Abstract][Full Text] [Related]
10. [Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy].
Ionescu SD; Sandru V; Leuciuc E; Manea P; Burdujan A; Tovarniţchi S; Cosovanu A
Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):128-31. PubMed ID: 12635373
[TBL] [Abstract][Full Text] [Related]
11. New aspects on inflammatory reactions and cough following inhibiton of angiotensin converting enzyme.
Lindgren BR
Acta Physiol Scand Suppl; 1988; 573():1-60. PubMed ID: 2466391
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
13. Erythema multiforme-like eruption in association with severe headache following pyritinol.
Nachbar F; Korting HC; Vogl T
Dermatology; 1993; 187(1):42-6. PubMed ID: 8324277
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
Cooke HM; De Besse A
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous vasculitis secondary to ramipril.
Gupta S; Gandhi NM; Ferguson J
J Drugs Dermatol; 2004; 3(1):81-2. PubMed ID: 14964753
[TBL] [Abstract][Full Text] [Related]
16. Enalapril-induced toxic pustuloderma.
Ferguson JE; Chalmers RJ
Clin Exp Dermatol; 1996 Jan; 21(1):54-5. PubMed ID: 8689772
[TBL] [Abstract][Full Text] [Related]
17. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Vlasses PH; Larijani GE; Conner DP; Ferguson RK
Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
Gündüz F; Kuru O; Sentürk UK
Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
[TBL] [Abstract][Full Text] [Related]
19. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M; Tylicki L; Rutkowski P; Rutkowski B
Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
[TBL] [Abstract][Full Text] [Related]
20. Recurrent erythema annulare centrifugum during ustekinumab treatment in a psoriatic patient.
Chou WT; Tsai TF
Acta Derm Venereol; 2013 Mar; 93(2):208-9. PubMed ID: 22983014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
